Dianthus Therapeutics, Inc. DNTH
Set alert
85.49 USD +3.24 +3.94%
As of Nov 3, 10:49 AM ET
82.24 Day range 85.96
32.42 52-week range 117.88
- YTD
- +107.45%
- 1 year
- +151.22%
- Open
- 83.21
- Prev close
- 82.25
- Mkt cap
- 4.67B
- Vol
- 62.66K
- Avg vol
- 813.26K
- EPS
- -4.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 82.24
- High
- 85.96
- Forward P/E
- -17.84
- Beta
- 0.26
- Short ratio
- 9.16
- Inst. own
- 129.89%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 92.76
- 200-d avg
- 85.03
- 1y target
- 139.06
6M chart
Events in this range
- May 5, 2026Earnings: -0.85; estimate -1.17; surprise 27.35%
- Aug 4, 2026Earnings: -0.9; estimate -0.84628; surprise -6.35%
- Aug 6, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 6, 2026Rating: Truist Securities · Buy → Buy
- Sep 4, 2026Rating: Citigroup · — → Buy
- Sep 11, 2026Rating: JP Morgan · — → Overweight
- Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 27, 2026Rating: Roth Capital · — → Buy
Signals (20)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 139.06 +62.7% upside
Now 85.49
- Target (low)
- 113.00
- Target (mean)
- 139.06
- Target (high)
- 200.00
Ratings (0m) 18 18 buy · 0 hold · 0 sell
- Strong buy1
- Buy17
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 18
- 1 month ago 17
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.94865 | -1.13 – -0.3929 | -0.97 | +2.2% | 388.66K | -1.8% | 10 |
| Next quarter | -1.11 | -1.36 – -0.9841 | -1.43 | +22.3% | 309.11K | +8.8% | 10 |
| Current year | -3.81 | -4.10 – -3.43 | -4.20 | +9.2% | 1.92M | -5.8% | 11 |
| Next year | -4.61 | -5.77 – -3.47 | -3.81 | -20.9% | 1.82M | -5.0% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Roth Capital | Initiated | — | Buy |
| Oct 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 11, 2026 | JP Morgan | Initiated | — | Overweight |
| Sep 4, 2026 | Citigroup | Initiated | — | Buy |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 5, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Apr 9, 2026 | Wolfe Research | Initiated | — | Outperform |
| Mar 19, 2026 | Wells Fargo | Initiated | — | Overweight |
| Mar 12, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Raymond James | Upgrade | Outperform | Strong Buy |
| Mar 10, 2026 | Baird | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Clear Street | Maintained | Buy | Buy |
| Mar 9, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 9, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 9, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 4, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 11, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 2, 2026 | Jefferies | Maintained | Buy | Buy |
| Jan 8, 2026 | Truist Securities | Maintained | Buy | Buy |
| Dec 22, 2025 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 10, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Oct 14, 2025 | Truist Securities | Initiated | — | Buy |
| Sep 17, 2025 | Clear Street | Initiated | — | Buy |
| Sep 12, 2025 | Stifel | Maintained | Buy | Buy |
| Sep 12, 2025 | Wedbush | Maintained | Outperform | Outperform |